BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2005
View Archived Issues
Weekly BMS-214662 regimen investigated in patients with solid tumors
Read More
Alvimopan reduces the duration of postoperative ileus
Read More
Rotigotine patch demonstrates safety and efficacy in Parkinson's disease
Read More
First European filing for new aerosol inhaler version of Pulmicort
Read More
New River seeks to begin clinical trials of NRP-290 for acute pain
Read More
Global Pharmatech licenses new anticancer drug
Read More
Tilarginine acetate injection studied for cardiogenic shock
Read More
In vivo results for QR-440 antiinflammatory compound
Read More
Cougar licenses rights to seocalcitol from LEO Pharma
Read More
Enrollment under way in phase I study of LAB CGRP for asthma
Read More
Novartis extends tender offer for Eon Labs
Read More
Oxigene updates vascular targeting programs in ophthalmology
Read More
Significant improvements achieved with recombinant leptin in generalized lipodystrophy
Read More
Flurizan under clinical evaluation for Alzheimer's disease
Read More
Promising results reported for long-term bosentan in PAH associated with scleroderma
Read More
Antifungal activity enhancers in early development at Kitasato Institute
Read More
Polypeptides for autoimmune diseases emerge from Baxter R&D
Read More
Ajinomoto reports ACC inhibitors for diabetes, etc.
Read More
New compounds for depression, ADHD, anxiety, etc. disclosed in recent patents
Read More
Novel C5a receptor antagonist shows efficacy and stability in a rat model of IBD
Read More
FDA accepts for review two Merck vaccine BLAs
Read More
MRHA requests more clinical trials for approval of cilansetron for IBS-D
Read More
Genta begins submissions for Genasense in U.S., E.U.
Read More
Takeda submits NDA for combination type 2 diabetes medication
Read More
Nonapprovable letter for PW-2101 for hypertension and angina
Read More
Avelox approved for complicated skin and skin structure infections
Read More
Avanir completes Neurodex NDA filing
Read More
BILR-355-BS shows potent antiviral activity against majority of NNRTI-resistant isolates
Read More